These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1506397)

  • 21. Pulmonary hypertensive effect of heparin and protamine interaction: evidence for thromboxane B2 release from the lung.
    Degges RD; Foster ME; Dang AQ; Read RC
    Am J Surg; 1987 Dec; 154(6):696-9. PubMed ID: 3425821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine.
    Hobbhahn J; Conzen PF; Zenker B; Goetz AE; Peter K; Brendel W
    Anesth Analg; 1988 Mar; 67(3):253-60. PubMed ID: 3125765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a thromboxane synthetase inhibitor on protamine-induced circulatory changes in sheep.
    Sugi K; Esato K
    Surgery; 1993 Sep; 114(3):586-90. PubMed ID: 8367815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep.
    Fratacci MD; Frostell CG; Chen TY; Wain JC; Robinson DR; Zapol WM
    Anesthesiology; 1991 Dec; 75(6):990-9. PubMed ID: 1741521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protamine-induced pulmonary venoconstriction in heparinized pigs.
    Hakim TS; Picone A; Oleary CE; Camporesi EM
    Anesth Analg; 1995 Jul; 81(1):38-43. PubMed ID: 7598279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effects of thromboxane receptor antagonist on hemodynamic responses after neutralization of heparin by protamine].
    Yoshioka M; Wakamatsu M; Kuro M; Okumura F
    Masui; 1991 Jun; 40(6):918-22. PubMed ID: 1875538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of endothelin-1 and thromboxane A2 in the pulmonary hypertension induced by heparin-protamine interaction in anesthetized dogs.
    Freitas CF; Faro R; Dragosavac D; Clozel M; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):106-12. PubMed ID: 14668575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary microvascular responses to protamine and histamine. Effects of cardiopulmonary bypass.
    Friedman M; Johnson RG; Wang SY; Dai HB; Thurer RL; Weintraub RM; Sellke FW
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1092-9. PubMed ID: 7983878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.
    Freitas CF; Morganti RP; Annichino-Bizzacchi JM; De Nucci G; Antunes E
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):10-4. PubMed ID: 17201729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The heparin-protamine interaction. A review.
    Carr JA; Silverman N
    J Cardiovasc Surg (Torino); 1999 Oct; 40(5):659-66. PubMed ID: 10596998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protamine-induced thrombocytopenia and leukopenia.
    Al-Mondhiry H; Pierce WS; Basarab RM
    Thromb Haemost; 1985 Feb; 53(1):60-4. PubMed ID: 3873119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboxane A2 receptor-specific antagonism in hypothermic cardiopulmonary bypass.
    Mendeloff EN; Liang IY; Swain JA; Clark RE
    Ann Thorac Surg; 1994 Apr; 57(4):999-1006. PubMed ID: 8166557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin.
    Fiser WP; Fewell JE; Hill DE; Barnes RW; Read RC
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):63-70. PubMed ID: 3965817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
    Stefaniszyn HJ; Novick RJ; Salerno TA
    J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depressed cardiovascular function and altered platelet kinetics following protamine sulfate reversal of heparin activity.
    Wakefield TW; Whitehouse WM; Stanley JC
    J Vasc Surg; 1984 Mar; 1(2):346-55. PubMed ID: 6481883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation.
    Morel DR; Lowenstein E; Nguyenduy T; Robinson DR; Repine JE; Chenoweth DE; Zapol WM
    Circ Res; 1988 May; 62(5):905-15. PubMed ID: 3129208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated administration of protamine does not attenuate circulatory changes caused by protamine reversal of heparin in dogs.
    Mizutani T; Takahashi S; Kihara S; Toyooka H
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):346-51. PubMed ID: 11426367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of prostaglandin E1 on pulmonary hypertension after protamine injection during cardiac surgery.
    Abe K; Sakakibara T; Miyamoto Y; Ohnishi K
    Eur J Clin Pharmacol; 1998 Mar; 54(1):21-5. PubMed ID: 9591925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil activation mediates protamine-induced pulmonary hypertension.
    Cho PW; Gillinov AM; Zehr KJ; Burch RM; Winkelstein JA; Cameron DE
    J Surg Res; 1993 May; 54(5):486-93. PubMed ID: 8103132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
    Rogers K; Milne B; Salerno TA
    J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.